Results 201 to 210 of about 217,588 (352)

Association of a remote monitoring programme with all‐cause mortality and hospitalizations in patients with heart failure: National‐scale, real‐world evidence from a 3‐year propensity score analysis of the TELESAT‐HF study

open access: yesEuropean Journal of Heart Failure, EarlyView.
Association of a remote monitoring programme (RMP) with all‐cause mortality and hospitalization in heart failure (HF) patients. COPD, chronic obstructive pulmonary oedema; HR, hazard ratio; ICU, intensive care unit; LTI, long‐term illness; RR, rate ratio; SoC, standard of care.
Nicolas Girerd   +12 more
wiley   +1 more source

Post-Hydralazine Renin Release in the Diagnosis of Renovascular Hypertension

open access: green, 1969
John A. Mannick   +2 more
openalex   +2 more sources

Registries on transcatheter edge‐to‐edge repair in heart failure: Current evidence and future perspectives

open access: yesEuropean Journal of Heart Failure, EarlyView.
Clinical evidence in transcatheter edge‐to‐edge valve repair. EF, ejection fraction; eGFR, estimated glomerular filtration rate; EROA, effective regurgitant orifice area; GDMT, guideline‐directed medical therapy; HF, heart failure; HHF, hospitalization for heart failure; LVEDV, left ventricular end‐diastolic volume; MR, mitral regurgitation; MVARC ...
Gianluigi Savarese   +13 more
wiley   +1 more source

Sacubitril/valsartan versus valsartan initiation in patients naïve to renin–angiotensin system inhibitors: Insights from PARAGLIDE‐HF

open access: yesEuropean Journal of Heart Failure, EarlyView.
Changes in N‐terminal pro‐B‐type natriuretic peptide and assessment of clinical endpoints according to prior exposure to renin–angiotensin system inhibitors in the Pre‐specified substudy of Prospective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF (PARAGLIDE‐HF).
Nina Nouhravesh   +14 more
wiley   +1 more source

An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock. [PDF]

open access: yesCrit Care
Leisman DE   +12 more
europepmc   +1 more source

Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant‐level pooled analysis of the CANVAS and CREDENCE trials

open access: yesEuropean Journal of Heart Failure, EarlyView.
Among high‐risk patients with T2D, new oral loop diuretic intensification was frequent and portended adverse prognostic significance. Treatment with canagliflozin significantly reduced the need for loop diuretic intensification. ABSTRACT Aims The sodium–glucose cotransporter 2 inhibitor canagliflozin reduces the risk of heart failure (HF ...
Safia Chatur   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy